Minocycline Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 16 USDMF, 6 CEP/COS, 3 JDMF, 2 KDMF, 12 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

47 Drugs in Development

47 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

176 FDF Dossiers, 138 FDA Orange Book, 3 Europe, 7 Canada, 2 Australia, 6 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 8 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 35 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 35 Direct Compression, 30 Controlled & Modified Release, 29 Thickeners and Stabilizers, 28 Lubricants & Glidants, 24 Solubilizers, 23 Disintegrants & Superdisintegrants, 23 Granulation, 20 Film Formers & Plasticizers, 18 Topical, 18 Co-Processed Excipients, 13 Parenteral, 10 Taste Masking, 9 Empty Capsules, 8 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 69 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 21 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

33 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

82 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50808 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
minocycline hydrochloride(UNII: 0020414E5U) (minocycline - UNII:FYY3R43WGO)	minocycline	105mg \| 80mg \| 55mg

Inactive Ingredients

Ingredient Name	Oceanside Pharmaceuticals
CARNAUBA WAX(R12CBM0EIZ)
D&C Red No. 27(2LRS185U6K)
FD&C Blue No. 1(H3R47K3TBD)
FD&C Blue No. 2(L06K8R7DQK)
FD&C Red No. 40(WZB9127XOA)
FD&C Yellow No. 6(H77VEI93A8)
HYPROMELLOSE 2910 (50 MPA.S)(1IVH67816N)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
SILICON DIOXIDE(ETJ7Z6XBU4)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIACETIN(XHX3C3X673)

Drug Product Composition: Minocycline Hydrochloride